Cargando…
The pathophysiological basis of pharmacological interventions in CAVD
Calcific aortic valve disease (CAVD) results in aortic valve stenosis and is one of the most common cardiac diseases in both Western and developing countries. The burden of this disease is expected to increase rapidly in the future, but there are still no relevant pharmacological therapies available...
Autores principales: | Riem Vis, P. W., van Rijswijk, J-W., Chamuleau, S. A. J., Vink, A., van Herwerden, L. A., Kluin, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370094/ https://www.ncbi.nlm.nih.gov/pubmed/22160992 http://dx.doi.org/10.1007/s12471-011-0230-1 |
Ejemplares similares
-
Contribution of Oxidative Stress (OS) in Calcific Aortic Valve Disease (CAVD): From Pathophysiology to Therapeutic Targets
por: Tanase, Daniela Maria, et al.
Publicado: (2022) -
Sequential use of human-derived medium supplements favours cardiovascular tissue engineering
por: Vis, Paul W Riem, et al.
Publicado: (2012) -
The first taxonomic and functional characterization of human CAVD-associated microbiota
por: Curini, Lavinia, et al.
Publicado: (2023) -
CAVD, towards better characterization of void space for ionic transport analysis
por: He, Bing, et al.
Publicado: (2020) -
P16-19. Statistical design and analysis of the CAVD-VIMC Elispot transfer study 001
por: Huang, Y, et al.
Publicado: (2009)